Triprolidine Hydrochloride Hydrate

盐酸曲普利啶

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameTriprolidine Hydrochloride Hydrate
Drug Alias Nametriprolidine吡啶盐酸盐triprolidinum盐酸丙吡咯啶triprolidina +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H1 receptor antagonists
TargetsHistamine H1 receptor
Therapy Area/IndicationsHypersensitivityCough
Global Approved IndicationsHypersensitivityCough
Approved Indications in ChinaHypersensitivity
Original Approved Country/TerritoryN/A
Original Approved Date1953/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesZhongshan Branch of Zhuhai United Laboratories Co Ltd
Inactive CompaniesN/A
Active IndicationsHypersensitivityCough
Inactive IndicationsN/A

Other Information

ATC CodeR06AX07
Related LinksWikipediaDrugBankKEGG